Zobrazeno 1 - 10
of 184
pro vyhledávání: '"Janos Szebeni"'
Autor:
Marwa Mohamed, Amr S. Abu Lila, Taro Shimizu, Eman Alaaeldin, Amal Hussein, Hatem A. Sarhan, Janos Szebeni, Tatsuhiro Ishida
Publikováno v:
Science and Technology of Advanced Materials, Vol 20, Iss 1, Pp 710-724 (2019)
A commonly held view is that nanocarriers conjugated to polyethylene glycol (PEG) are non-immunogenic. However, many studies have reported that unexpected immune responses have occurred against PEG-conjugated nanocarriers. One unanticipated response
Externí odkaz:
https://doaj.org/article/28d96beefcd0435db1f50eb1d8a4112f
Autor:
Janos Szebeni
Publikováno v:
World Allergy Organization Journal, Vol 13, Iss 8, Pp 100250- (2020)
Externí odkaz:
https://doaj.org/article/b9f34c30341a4919bd5ed771ad5b3809
Publikováno v:
World Allergy Organization Journal, Vol 13, Iss 8, Pp 100178- (2020)
Externí odkaz:
https://doaj.org/article/ab37c4e6f067449d90dc14102050f855
Autor:
Shubhadeep Banerjee, Jayeeta Sengupta, Ana Isabel Aljarilla, Francesca Setaro, Petri Makinen, LinPing Wu, Lari Holappa, Andres de la Escosura, Chiara Martinelli, Panagiotis Trohopoulos, Seppo Ylä-Herttuala, Rudolf Urbanics, Janos Szebeni, Tomas Torres, Silke Krol
Publikováno v:
Precision Nanomedicine, Vol 2, Iss 2 (2019)
Diseases caused by obstruction or rupture of vulnerable plaques in the arterial walls such as cardiovascular infarction or stroke are the leading cause of death in the world. In the present work, we developed human serum albumin nanoparticles loaded
Externí odkaz:
https://doaj.org/article/5de7a6cca48e4049a9cb820aeea9c8ab
Autor:
Ahad Zare, Ali Akbar Pourfathollah, Zahra Pourpak, Janos Szebeni, Seyed Mohammad Reza Ghaffari, Gholam Ali Kardar
Publikováno v:
Iranian Journal of Allergy, Asthma and Immunology, Vol 16, Iss 4 (2017)
Current therapeutic approaches in allergic diseases especially asthma generally focus on using immunological strategies. According to the importance of FceRI in controlling allergic response we used two extracellular regions of Fc epsilon receptor I
Externí odkaz:
https://doaj.org/article/e1313bb7623046e292308afc365fab45
Publikováno v:
Molecules, Vol 23, Iss 7, p 1700 (2018)
Infusion reactions (IRs) are common immune-mediated side effects in patients treated with a variety of drug products, including, but not limited to, nanotechnology formulations. The mechanism of IRs is not fully understood. One of the best studied me
Externí odkaz:
https://doaj.org/article/1e0189f8a9414b54b8a6469fb776f88b
Autor:
Edward Cedrone, Barry W. Neun, Jamie Rodriguez, Alison Vermilya, Jeffrey D. Clogston, Scott E. McNeil, Yechezkel Barenholz, Janos Szebeni, Marina A. Dobrovolskaia
Publikováno v:
Molecules, Vol 23, Iss 1, p 12 (2017)
The preclinical safety assessment of novel nanotechnology-based drug products frequently relies on in vitro assays, especially during the early stages of product development, due to the limited quantities of nanomaterials available for such studies.
Externí odkaz:
https://doaj.org/article/7af0fd1578c248ba9013c602b4599551
Autor:
David Rampton, Joergen Folkersen, Steven Fishbane, Michael Hedenus, Stefanie Howaldt, Francesco Locatelli, Shalini Patni, Janos Szebeni, Guenter Weiss
Publikováno v:
Haematologica, Vol 99, Iss 11 (2014)
Intravenous iron is widely used for the treatment of iron deficiency anemia when oral iron is inappropriate, ineffective or poorly tolerated. Acute hypersensitivity reactions during iron infusions are very rare but can be life-threatening. This paper
Externí odkaz:
https://doaj.org/article/8db2d2a6b716448f9b955184a5c64b6c
Autor:
Bálint András Barta, Tamás Radovits, Attila Balázs Dobos, Gergely Tibor Kozma, Tamás Mészáros, Petra Berényi, Réka Facskó, Tamás Fülöp, Béla Merkely, János Szebeni
Publikováno v:
Vaccine: X, Vol 19, Iss , Pp 100497- (2024)
Background: Comirnaty, Pfizer-BioNTech's polyethylene-glycol (PEG)-containing Covid-19 vaccine, can cause hypersensitivity reactions (HSRs), or rarely, life-threatening anaphylaxis in a small fraction of immunized people. A causal role of anti-PEG an
Externí odkaz:
https://doaj.org/article/c662ffa9395d4c778d5fb5b02939d387
Autor:
Alberto Gabizon, Janos Szebeni
Publikováno v:
ACS Nano. 14:7682-7688
In this issue of ACS Nano, Chen et al. provide in vitro and in vivo evidence for monoclonal anti-poly(ethylene glycol) (anti-PEG) antibody-triggered, complement terminal complex-mediated damage to PEGylated liposomal doxorubicin, entailing the releas